Proteolytic Characteristics of Cathepsin D Related to the Recognition and Cleavage of Its Target Proteins

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Sun, Huiying ^a,b   Lou, Xiaomin ^a   Shan, Qiang ^a,b   Zhang, Ju ^a   Zhu, Xu ^a,b   Zhang, Jia ^c   Wang, Yang ^a,b   Xie, Yingying ^a,b   Xu, Ningzhi ^d   Liu, Siqi ^a  

^a China National Center for Bioinformation   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c Beijing Protein Innovation   (China)

^d CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; CATHEPSIN D; OVALBUMIN; PEPTIDE; PROTEIN;

ALPHA HELIX; ARTICLE; CONTROLLED STUDY; ENZYME SUBSTRATE; GENE SILENCING; HYDROPHOBICITY; LIQUID CHROMATOGRAPHY; MICROENVIRONMENT; MOLECULAR RECOGNITION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DENATURATION; PROTEIN SECONDARY STRUCTURE; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

AMINO ACID SEQUENCE; ANIMALS; CATHEPSIN D; CATTLE; CELL LINE, TUMOR; CHICKENS; CONSENSUS SEQUENCE; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MOLECULAR SEQUENCE DATA; OVALBUMIN; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, SECONDARY; PROTEOLYSIS; SERUM ALBUMIN, BOVINE; SUBSTRATE SPECIFICITY; SUS SCROFA;

BOVINAE;

EID: 84879258031     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065733     Document Type: Article

References (43)

1. Shree T, Olson OC, Elie BT, Kester JC, Garfall AL, et al. (2011) Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes & Development 25: 2465-2479.
2. Kirana C, Shi H, Laing E, Hood K, Miller R, et al. (2012) Cathepsin D Expression in Colorectal Cancer: From Proteomic Discovery through Validation Using Western Blotting, Immunohistochemistry, and Tissue Microarrays. International Journal of Proteomics 2012: 1-10.
3. Pecar Fonovic U, Jevnikar Z, Rojnik M, Doljak B, Fonovic M, et al. (2013) Profilin 1 as a target for cathepsin X activity in tumor cells. PloS one 8: e53918.
4. Sjöberg S, Shi G-P, (2011) Cysteine Protease Cathepsins in Atherosclerosis and Abdominal Aortic Aneurysm. Clinical Reviews in Bone and Mineral Metabolism 9: 138-147.
5. Raptis SZ, Shapiro SD, Simmons PM, Cheng AM, Pham CTN, (2005) Serine Protease Cathepsin G Regulates Adhesion-Dependent Neutrophil Effector Functions by Modulating Integrin Clustering. Immunity 22: 679-691.
6. Bever Jr CT, Garver DW, (1995) Increased cathepsin B activity in multiple sclerosis brain. Journal of the Neurological Sciences 131: 71-73.
7. Cullen V, Lindfors M, Ng J, Paetau A, Swinton E, et al. (2009) Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol Brain 2: 5.
8. Victor BC, Anbalagan A, Mohamed MM, Sloane BF, Cavallo-Medved D, (2011) Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasion. Breast Cancer Res 13: R115.
9. Lombardi G, Burzyn D, Mundinano J, Berguer P, Bekinschtein P, et al. (2005) Cathepsin-L influences the expression of extracellular matrix in lymphoid organs and plays a role in the regulation of thymic output and of peripheral T cell number. J Immunol 174: 7022-7032.
10. Handley CJ, Mok MT, Ilic MZ, Adcocks C, Buttle DJ, et al. (2001) Cathepsin D cleaves aggrecan at unique sites within the interglobular domain and chondroitin sulfate attachment regions that are also cleaved when cartilage is maintained at acid pH. Matrix Biol 20: 543-553.
11. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF, (1992) Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J 282 (Pt 1): 273-278.
12. Glondu M, Liaudet-Coopman E, Derocq D, Platet N, Rochefort H, et al. (2002) Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells. Oncogene 21: 5127-5134.
13. Conus S, Pop C, Snipas SJ, Salvesen GS, Simon HU, (2012) Cathepsin D Primes Caspase-8 Activation by Multiple Intra-chain Proteolysis. Journal of Biological Chemistry 287: 21142-21151.
14. Carew JS, Espitia CM, Esquivel JA 2nd, Mahalingam D, Kelly KR, et al (2011) Lucanthone is a novel inhibitor of autophagy that induces cathepsin D-mediated apoptosis. J Biol Chem 286: 6602-6613.
15. Byun HO, Han NK, Lee HJ, Kim KB, Ko YG, et al. (2009) Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence. Cancer Res 69: 4638-4647.
16. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, et al. (1995) Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J 14: 3599-3608.
17. Hu L, Roth JM, Brooks P, Luty J, Karpatkin S, (2008) Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis. Cancer Res 68: 4666-4673.
18. Kaschina E, Scholz H, Steckelings UM, Sommerfeld M, Kemnitz UR, et al. (2009) Transition from atherosclerosis to aortic aneurysm in humans coincides with an increased expression of RAS components. Atherosclerosis 205: 396-403.
19. Hakala JK, Oksjoki R, Laine P, Du H, Grabowski GA, et al. (2003) Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 23: 1430-1436.
20. Urbanelli L, Emiliani C, Massini C, Persichetti E, Orlacchio A, et al. (2008) Cathepsin D expression is decreased in Alzheimer's disease fibroblasts. Neurobiol Aging 29: 12-22.
21. Bednarski E, Lynch G, (1996) Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. J Neurochem. 67: 1846-1855.
22. van Noort JM, van der Drift AC, (1989) The selectivity of cathepsin D suggests an involvement of the enzyme in the generation of T-cell epitopes. J Biol Chem 264: 14159-14164.
23. Turkewitz AP, Schwartz AL, Harrison SC, (1988) A pH-dependent reversible conformational transition of the human transferrin receptor leads to self-association. J Biol Chem 263: 16309-16315.
24. Pimenta DC, Oliveira A, Juliano MA, Juliano L, (2001) Substrate specificity of human cathepsin D using internally quenched fluorescent peptides derived from reactive site loop of kallistatin. Biochim Biophys Acta 1544: 113-122.
25. Athauda SB, Takahashi K, (2002) Cleavage specificities of aspartic proteinases toward oxidized insulin B chain at different pH values. Protein Pept Lett 9: 289-294.
26. Fruitier I, Garreau I, Piot JM, (1998) Cathepsin D is a good candidate for the specific release of a stable hemorphin from hemoglobin in vivo: VV-hemorphin-7. Biochem Biophys Res Commun 246: 719-724.
27. Brindley PJ, Kalinna BH, Wong JY, Bogitsh BJ, King LT, et al. (2001) Proteolysis of human hemoglobin by schistosome cathepsin D. Mol Biochem Parasitol. 112: 103-112.
28. Hughes MC, Healy A, McSweeney PL, O'Neill EE, (2000) Proteolytic specificity of cathepsin D on bovine F-actin. Meat Sci 56: 165-172.
29. Pimenta DC, Chen VC, Chao J, Juliano MA, Juliano L, (2000) Alpha1-antichymotrypsin and kallistatin hydrolysis by human cathepsin D. J Protein Chem. 19: 411-418.
30. Schilling O, Overall CM, (2007) Proteomic discovery of protease substrates. Current opinion in chemical biology 11: 36-45.
31. Schilling O, Overall CM, (2008) Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nature biotechnology 26: 685-694.
32. Christensen B, Schack L, Klaning E, Sorensen ES, (2010) Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D. J Biol Chem. 285: 7929-7937.
33. Impens F, Colaert N, Helsens K, Ghesquiere B, Timmerman E, et al. (2010) A quantitative proteomics design for systematic identification of protease cleavage events. Mol Cell Proteomics 9: 2327-2333.
34. Offermann MK, Chlebowski JF, Bond JS, (1983) Action of cathepsin D on fructose-1,6-bisphosphate aldolase. Biochem J 211: 529-534.
35. Ohri SS, Vashishta A, Proctor M, Fusek M, Vetvicka V, (2007) Depletion of procathepsin D gene expression by RNA interference: a potential therapeutic target for breast cancer. Cancer Biol Ther 6: 1081-1087.
36. Schneider TD, Stephens RM, (1990) Sequence logos: a new way to display consensus sequences. Nucleic Acids Res 18: 6097-6100.
37. Cowan R, Whittaker RG, (1990) Hydrophobicity indices for amino acid residues as determined by high-performance liquid chromatography. Pept Res 3: 75-80.
38. Wimley WC, White SH, (1996) Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat Struct Biol 3: 842-848.
39. Appelqvist H, Johansson AC, Linderoth E, Johansson U, Antonsson B, et al. (2012) Lysosome-mediated apoptosis is associated with cathepsin D-specific processing of bid at Phe24, Trp48, and Phe183. Ann Clin Lab Sci 42: 231-242.
40. Melzer IM, Fernandez SB, Bosser S, Lohrig K, Lewandrowski U, et al. (2012) The Apaf-1-binding protein Aven is cleaved by Cathepsin D to unleash its anti-apoptotic potential. Cell Death Differ 19: 1435-1445.
41. Palashoff MH (2008) Determining the specificity of pepsin for proteolytic digestion. Chemistry Master's Theses Paper 1.
42. Impens F, Timmerman E, Staes A, Moens K, Arien KK, et al. (2012) A catalogue of putative HIV-1 protease host cell substrates. Biol Chem 393: 915-931.
43. Moller KK, Rattray FP, Ardo Y, (2012) Camel and Bovine Chymosin Hydrolysis of Bovine α(S1)- and β-Caseins Studied by Comparative Peptide Mapping. J Agric Food Chem 60: 11421-11432.